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INTRODUCTION. It is recognised that critically ill patients require the multidisciplinary team to 
receive optimum care. Specialist clinical Pharmacists (SCPs) have been shown to improve 
clinical and economic outcomes of patients contributing to their care by preventing medication 
errors, rationalising therapy, identifying interactions or suggesting alternative therapies. [1,2] 
OBJECTIVES. To describe SCP activity and interventions across a range of critical care units 
in the UK. To provide essential data 1,2n rate of ICU prescribing error and prescription 
optimization, to identify the mechanism and impact of each intervention in the prevention of 
harm and improve patient therapy.  
METHODS. A prospective observational study was undertaken in 21 critical care units over 
the United Kingdom (UK) from 5-18th Nov 2012 inclusive. A data collection web portal was 
designed where SCP recorded all interventions. Each intervention was classified into either: 
prescribing error, optimisation and consult. In addition, a scale of clinical impact was used to 
code the interventions. Interventions were scored as low, moderate, high impact and life 
saving.  
RESULTS. 20,740 prescriptions were reviewed with 3,390 interventions recorded by the SCP. 
This resulted in an overall intervention rate of 16.3%: 6.8% were classified as prescribing 
errors, 8.3 % optimisations and 1% consults. Using the scale the interventions were classified 
as: low impact (33.6%), moderate impact (47.1%) high impact (19.3%) and one as life saving. 
CONCLUSIONS. This observational study demonstrates that both prescribing error and 
optimisation rates were high. Almost 1 in 6 prescriptions required an intervention from the 
SCP. Error rate was similar to an 3earlier error study (EQUIP) [3]. Two thirds of the 
interventions were of at least moderate impact. SCPs embedded into the critical care team 
provide a valuable contribution, reducing patient harm from medication errors and optimising 
pharmacotherapy.  
REFERENCE(S).  
[1] Kane SL, Weber RJ, et al. The impact of critical care pharmacists on enhancing patient 
outcomes. Intensive Care Med. 2003;29:691–698.  
[2] MacLaren R, Bond CA, et al. Clinical and economic outcomes of involving pharmacists in 
the direct care of critically ill patients with infections. Crit Care Med. 2008;36:3184–3189.  
[3] How to reduce prescribing errors. The Lancet. 2009;374:1945 
GRANT ACKNOWLEDGMENT.  
United Kingdom Clinical Pharmacy Association (UKCPA) 
The NIHR Biomedical Research Centre, GSTT 
 
 
References 
 
 1.  Ackland G, Safadeh M, Smith M, Shulman R. Etomidate Is Not Associated with Greater 
Need for Vasopressor Support in Critically Ill Patients (abstract). American Society of 
Anaesthesiologists Annual Meeting 2007;1735 
Ref Type: Journal 
 2.  Costa MH, Shulman R, Bates I. A credentialing process for advanced level 
pharmacists: participant feedback. Pharmaceutical Journal 2012;288:1-5 
Ref Type: Journal 
 3.  Eilsbroek E, Howell DCJ, Smith F, Shulman R. Medication issues experienced by 
patients and carers after discharge from the intensive care uni. J Crit Care 2013;28:46-
50 
Ref Type: Journal 
 
 
